BUY Supriya Lifescience Limited — Choice Broking
byChoice BrokingHorizon: NA (inferred 1–3 months)6 Jul 2026via Economic Times New Stock Recos
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Supriya Lifescience FY26 net profit rises 11% to ₹2,091.2 million
NewsGoogle News·27 Sept · 1w ago
Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026
NewsGoogle News·25 Sept · 1w ago
Supriya Lifescience FY26 net profit rises 11% to ₹2,091.2 million
NewsGoogle News·20 Sept · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Supriya Lifescience
- BUY — Kush Bohra29 Sept 2026 · ~2 weeks · target ₹1,020 · SL hit
- BUY — Madhu Bansal29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY — Om Mehra, SAMCO Securities28 Sept 2026 · ~2 weeks · target ₹1,060 · SL hit
- BUY — Dharmesh Shah, ICICI Securities24 Sept 2026 · ~2 weeks · target ₹1,011 · Target hit
- BUY — Om Mehra, SAMCO Securities21 Sept 2026 · ~2 weeks · target ₹980 · Target hit
More from Choice Broking
- BUY Aptus Value Housing Finance India14 Oct 2026 · ~1 year · target ₹330 · Active
- BUY Rishabh Instruments9 Oct 2026 · ~1 year · target ₹830 · Active
- BUY Granules India1 Oct 2026 · ~1 year · target ₹1,010 · Active
- BUY Yatharth Hospital & Trauma Care Services30 Sept 2026 · ~1 year · target ₹1,350 · Active
- BUY Sambhv Steel Tubes29 Sept 2026 · ~1 year · target ₹210 · Active

